Equities

Outset Medical Inc

OM:NSQ

Outset Medical Inc

Actions
  • Price (USD)3.00
  • Today's Change-0.270 / -8.26%
  • Shares traded849.63k
  • 1 Year change-85.65%
  • Beta1.9052
Data delayed at least 15 minutes, as of May 10 2024 16:53 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Outset Medical, Inc. is a medical technology company. The Company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The Company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by virtually anyone. The Tablo system comprises components, which include Tablo Console, Tablo Cartridge and Tablo Data Ecosystem. Tablo Console is a compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.

  • Revenue in USD (TTM)130.38m
  • Net income in USD-172.80m
  • Incorporated2003
  • Employees480.00
  • Location
    Outset Medical Inc3052 Orchard DriveSAN JOSE 95134United StatesUSA
  • Phone+1 (971) 563-3083
  • Fax+1 (302) 655-5049
  • Websitehttps://outsetmedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Fonar Corp102.42m12.16m117.29m561.0010.030.71585.641.151.741.7414.6024.420.512420.351.44182,570.608.338.738.649.6045.6748.3316.2516.399.15--0.0055--1.083.89-24.71-15.058.48--
TELA Bio Inc58.45m-46.66m121.79m227.00--6.41--2.08-2.06-2.062.560.77080.80131.477.15257,502.20-63.97-52.00-80.09-60.9568.6265.32-79.83-107.653.45-8.440.6821--41.1347.85-5.35---17.12--
Delcath Systems Inc2.07m-47.68m141.44m76.00--8.02--68.50-2.98-2.980.12730.69310.07310.23876.8027,171.05-168.85-116.57-377.02-243.2169.2571.02-2,308.86-1,235.372.06-26.530.3915---24.05-9.53-30.60---5.26--
Electromed Inc53.50m4.36m150.70m170.0035.233.5429.112.820.49420.49426.084.921.173.312.25314,682.309.497.8611.039.1476.4176.258.147.385.87--0.000.0015.3811.1737.3511.0024.58--
CVRx Inc42.09m-52.01m157.86m200.00--2.38--3.75-2.48-2.482.013.070.36780.67815.64210,430.00-45.45---48.95--84.45---123.58--10.87-21.110.3064--74.89--0.5528------
InfuSystem Holdings Inc125.79m872.00k160.76m499.00190.763.0611.971.280.03960.03965.862.471.2411.176.85252,074.100.86214.601.015.6950.1756.430.69334.071.541.880.35750.0014.4413.384,744.44--6.01--
Semler Scientific Inc65.88m21.69m162.23m92.008.262.047.262.462.782.788.4511.260.85515.138.51716,097.8028.1438.8331.1444.4189.4390.2232.9232.5812.11--0.00--20.2825.9843.6932.64-0.3821--
Clearpoint Neuro Inc23.96m-22.09m167.54m107.00--7.11--6.99-0.8979-0.89790.97360.85890.48811.208.15223,878.50-45.01-34.75-52.63-39.6756.8364.75-92.21-76.913.80--0.3197--16.5626.64-34.40--75.30--
Accuray Inc430.55m-21.49m167.60m1.02k--4.08--0.3893-0.2197-0.21974.420.41430.91781.865.72420,462.90-4.58-1.45-7.84-2.4833.0637.86-4.99-1.620.778-0.38570.8086--4.122.03-73.56--13.92--
Outset Medical Inc130.38m-172.80m169.07m480.00--1.34--1.30-3.49-3.492.642.440.36522.014.27271,616.70-48.41-41.40-56.97-47.2922.245.71-132.54-159.054.37-67.800.5143--13.00130.43-6.04--14.27--
Orchestra Biomed Holdings Inc2.76m-49.12m177.14m56.00--2.60--64.18-1.49-1.490.08321.900.02890.881528.3149,285.71-51.49---61.01--93.26---1,779.71--7.94--0.00---21.88---37.91------
Stereotaxis Inc26.77m-22.06m179.86m122.00--10.85--6.72-0.2737-0.27370.33180.27080.56171.466.01219,434.40-43.46-25.02-61.11-34.1255.5167.57-77.37-41.901.88--0.00---4.89-1.82-12.33--6.63--
Inogen Inc315.66m-102.45m204.62m834.00--0.9897--0.6482-4.42-4.4213.628.780.86346.766.01378,489.20-28.02-8.23-34.53-9.5340.1444.54-32.46-10.312.56--0.00---16.32-2.49-22.30--26.34--
Butterfly Network Inc68.08m-121.92m205.44m225.00--1.01--3.02-0.5893-0.58930.3290.96850.20450.69544.97302,577.80-36.61---42.07--26.50---179.08--3.34--0.00---10.21--20.76------
Akoya Biosciences Inc96.63m-63.32m221.05m330.00--4.09--2.29-1.48-1.482.181.090.54232.497.23292,827.30-35.53---44.59--58.27---65.53--2.94-10.940.5882--29.09--10.36------
Data as of May 10 2024. Currency figures normalised to Outset Medical Inc's reporting currency: US Dollar USD

Institutional shareholders

68.78%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 31 Dec 20237.04m13.94%
Columbia Wanger Asset Management LLCas of 31 Mar 20245.11m10.12%
The Vanguard Group, Inc.as of 31 Dec 20233.84m7.61%
BlackRock Fund Advisorsas of 31 Dec 20233.54m7.02%
Morgan Stanley & Co. LLCas of 31 Dec 20233.36m6.65%
T. Rowe Price Investment Management, Inc.as of 31 Dec 20233.17m6.27%
JPMorgan Investment Management, Inc.as of 31 Dec 20232.64m5.22%
Braidwell LPas of 31 Dec 20232.40m4.75%
JPMorgan Asset Management (UK) Ltd.as of 31 Dec 20231.87m3.71%
Bellevue Asset Management AGas of 31 Dec 20231.76m3.49%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.